90 related articles for article (PubMed ID: 27840914)
1. RNASET2 silencing affects miRNAs and target gene expression pattern in a human ovarian cancer cell model.
Turconi G; Scaldaferri D; Fabbri M; Monti L; Lualdi M; Pedrini E; Gribaldo L; Taramelli R; Acquati F
Int J Oncol; 2016 Dec; 49(6):2637-2646. PubMed ID: 27840914
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of tumor suppressor gene ribonuclease T2 and gametogenetin binding protein 2 is associated with drug resistance in ovarian cancer.
Yin F; Liu L; Liu X; Li G; Zheng L; Li D; Wang Q; Zhang W; Li L
Oncol Rep; 2014 Jul; 32(1):362-72. PubMed ID: 24842157
[TBL] [Abstract][Full Text] [Related]
3. Tumor and metastasis suppression by the human RNASET2 gene.
Acquati F; Possati L; Ferrante L; Campomenosi P; Talevi S; Bardelli S; Margiotta C; Russo A; Bortoletto E; Rocchetti R; Calza R; Cinquetti R; Monti L; Salis S; Barbanti-Brodano G; Taramelli R
Int J Oncol; 2005 May; 26(5):1159-68. PubMed ID: 15809705
[TBL] [Abstract][Full Text] [Related]
4. Pleiotropic modes of action in tumor cells of RNASET2, an evolutionary highly conserved extracellular RNase.
Lualdi M; Pedrini E; Rea K; Monti L; Scaldaferri D; Gariboldi M; Camporeale A; Ghia P; Monti E; Tomassetti A; Acquati F; Taramelli R
Oncotarget; 2015 Apr; 6(10):7851-65. PubMed ID: 25797262
[TBL] [Abstract][Full Text] [Related]
5. Intracellular trafficking of RNASET2, a novel component of P-bodies.
Vidalino L; Monti L; Haase A; Moro A; Acquati F; Taramelli R; Macchi P
Biol Cell; 2012 Jan; 104(1):13-21. PubMed ID: 22188480
[TBL] [Abstract][Full Text] [Related]
6. Human RNASET2: A Highly Pleiotropic and Evolutionary Conserved Tumor Suppressor Gene Involved in the Control of Ovarian Cancer Pathogenesis.
Bruno A; Noonan DM; Valli R; Porta G; Taramelli R; Mortara L; Acquati F
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012339
[TBL] [Abstract][Full Text] [Related]
7. New Strategies for Expression and Purification of Recombinant Human RNASET2 Protein in Pichia pastoris.
Lualdi M; Pedrini E; Petroni F; Näsman J; Lindqvist C; Scaldaferri D; Taramelli R; Inforzato A; Acquati F
Mol Biotechnol; 2015 Jun; 57(6):513-25. PubMed ID: 25663099
[TBL] [Abstract][Full Text] [Related]
8. Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase.
Acquati F; Bertilaccio S; Grimaldi A; Monti L; Cinquetti R; Bonetti P; Lualdi M; Vidalino L; Fabbri M; Sacco MG; van Rooijen N; Campomenosi P; Vigetti D; Passi A; Riva C; Capella C; Sanvito F; Doglioni C; Gribaldo L; Macchi P; Sica A; Noonan DM; Ghia P; Taramelli R
Proc Natl Acad Sci U S A; 2011 Jan; 108(3):1104-9. PubMed ID: 21189302
[TBL] [Abstract][Full Text] [Related]
9. Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cells.
Acquati F; Monti L; Lualdi M; Fabbri M; Sacco MG; Gribaldo L; Taramelli R
Oncotarget; 2011 Jun; 2(6):477-84. PubMed ID: 21646684
[TBL] [Abstract][Full Text] [Related]
10. Characterization of RNASET2, the first human member of the Rh/T2/S family of glycoproteins.
Campomenosi P; Salis S; Lindqvist C; Mariani D; Nordström T; Acquati F; Taramelli R
Arch Biochem Biophys; 2006 May; 449(1-2):17-26. PubMed ID: 16620762
[TBL] [Abstract][Full Text] [Related]
11. FBXO6-mediated RNASET2 ubiquitination and degradation governs the development of ovarian cancer.
Ji M; Zhao Z; Li Y; Xu P; Shi J; Li Z; Wang K; Huang X; Liu B
Cell Death Dis; 2021 Mar; 12(4):317. PubMed ID: 33767133
[TBL] [Abstract][Full Text] [Related]
12. Loss of function of Ribonuclease T2, an ancient and phylogenetically conserved RNase, plays a crucial role in ovarian tumorigenesis.
Acquati F; Lualdi M; Bertilaccio S; Monti L; Turconi G; Fabbri M; Grimaldi A; Anselmo A; Inforzato A; Collotta A; Cimetti L; Riva C; Gribaldo L; Ghia P; Taramelli R
Proc Natl Acad Sci U S A; 2013 May; 110(20):8140-5. PubMed ID: 23630276
[TBL] [Abstract][Full Text] [Related]
13. Expression and purification of the human tumor suppressor protein RNASET2 in CHO-S cells.
Rosini E; De Vito A; Ponti F; Scaldaferri D; Pollegioni L; Acquati F
Protein Expr Purif; 2020 Oct; 174():105675. PubMed ID: 32450138
[TBL] [Abstract][Full Text] [Related]
14. Chromosome 6 encoded RNaseT2 protein is a cell growth regulator.
Liu J; Zhawar VK; Kaur G; Kaur GP; Deriel JK; Kandpal RP; Athwal RS
J Cell Mol Med; 2010 May; 14(5):1146-55. PubMed ID: 19382914
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the baculovirus-insect cell and Pichia pastoris heterologous systems for the expression of the human tumor suppressor protein RNASET2.
Campomenosi P; Cinquetti R; Tallarita E; Lindqvist C; Raimondi I; Grassi P; Näsman J; Dell A; Haslam SM; Taramelli R; Acquati F
Biotechnol Appl Biochem; 2011; 58(1):39-49. PubMed ID: 21446958
[TBL] [Abstract][Full Text] [Related]
16. RNASET2 as a tumor antagonizing gene in a melanoma cancer model.
Monti L; Rodolfo M; Lo Russo G; Noonan D; Acquati F; Taramelli R
Oncol Res; 2008; 17(2):69-74. PubMed ID: 18543608
[TBL] [Abstract][Full Text] [Related]
17. MiR-718 represses VEGF and inhibits ovarian cancer cell progression.
Leng R; Zha L; Tang L
FEBS Lett; 2014 Jun; 588(12):2078-86. PubMed ID: 24815691
[TBL] [Abstract][Full Text] [Related]
18. MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression.
Chen WT; Yang YJ; Zhang ZD; An Q; Li N; Liu W; Yang B
J Ovarian Res; 2017 Jan; 10(1):1. PubMed ID: 28086946
[TBL] [Abstract][Full Text] [Related]
19. Innate Immune Response Regulation by the Human
Acquati F; Mortara L; De Vito A; Baci D; Albini A; Cippitelli M; Taramelli R; Noonan DM
Front Immunol; 2019; 10():2587. PubMed ID: 31749812
[TBL] [Abstract][Full Text] [Related]
20. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
